🚀 Early-career faculty, launch your career with AGA’s Research Scholar Award. This career development award supports basic and clinical investigators with $100,000 a year for three years, enabling you to: 🕐 Secure protected time for high-impact research ♻️ Create a sustainable path to future funding 📈 Establish yourself as an investigator Seize the opportunity to launch your work in digestive disease research funding with the benefit of long-term support and national recognition. Applications due Dec. 3. https://ow.ly/vpSI50Xlaf8
American Gastroenterological Association (AGA)
Non-profit Organizations
Bethesda, MD 19,749 followers
Empowering clinicians and researchers to improve digestive health.
About us
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include over 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization.
- Website
-
http://www.gastro.org
External link for American Gastroenterological Association (AGA)
- Industry
- Non-profit Organizations
- Company size
- 51-200 employees
- Headquarters
- Bethesda, MD
- Type
- Nonprofit
- Founded
- 1897
Locations
-
Primary
Get directions
4930 Del Ray Avenue
Bethesda, MD 20814, US
Employees at American Gastroenterological Association (AGA)
Updates
-
We were thrilled to connect with an inspiring group of young researchers from Beijing Friendship Hospital, who have been translating select Gastroenterology abstracts for Chinese social media audiences. A huge thank-you to this dedicated team — and Prof. Haiyun Shi — for their outstanding work! 🌍📚 Alison Kim Paul Moayyedi
-
-
🚨 Last Call to Register! Join us on Nov. 4, 12–1 p.m. ET for a powerful #GastroBites session on preventing cirrhosis decompensation before it starts. Learn from leading experts Drs. Kimberly Brown, Apurva Modi & Arun Jesudian, MD about: ▪️Gut dysbiosis and the gut–liver–brain axis ▪️Hepatic encephalopathy (#HE) as an early complication ▪️Emerging strategies for preventing decompensation 💲Free for members & nonmembers. 🔗Register now: https://ow.ly/fl0Z50Xj0kx Sponsored by Salix Pharmaceuticals
-
-
🔔 For #LiverAwarenessMonth, we've highlighted a few recent and high impact #Gastro articles with a focus on liver: ➡️A Phase 3 Biomarker Validation of GALAD for the Detection of HCC in Cirrhosis: https://ow.ly/raWS50XgXhs ➡️Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype): https://ow.ly/xoqU50XgXht ➡️Adipose Tissue Macrophages in Metabolic Dysfunction–Associated Steatohepatitis Secrete Extracellular Vesicles That Activate Liver Fibrosis in Obese Male Mice: https://ow.ly/kjEC50XgXhw 📖 A recent #CMGH study also found that "Continuous Activation of C/EBPβ Transcription Factor Prevents Fibrosis Resolution After Alcohol Cessation" https://ow.ly/2VqM50XgXhv Check out the graphical abstract below ⬇️
-
-
We’re seeking public feedback on newly proposed quality indicators for inflammatory bowel disease (IBD) care. These measurable, evidence-based standards provide a framework for delivering high-quality, guideline-supported care for patients with Crohn’s disease and ulcerative colitis — helping reduce care variation and improve outcomes. The proposed indicators address key aspects of IBD management, such as: ✅ Avoiding long-term corticosteroid use ✅ Transitioning to steroid-sparing therapies ✅ Initiating biologic or small molecule therapy for moderate to severe disease Regular objective monitoring for inflammation 🗓️ Submit your feedback by Nov. 29: https://ow.ly/wA4U50XksNu
-
Explore complete GI and hepatology clinical updates with the 2025 AGA-ASGE Postgraduate Course OnDemand recording. Gain entry to the most comprehensive clinical updates, expert-led sessions, and practical strategies—anytime, anywhere all while earning CME credits. Don’t miss out on the best-reviewed course in years! 🔗 Learn more and access: https://ow.ly/PtLl50XiBOQ
-
-
No leader succeeds alone. That’s why the AGA Women’s Executive Leadership Conference exists: to bring women in GI and hepatology together to share challenges, strategies, and successes. Join a cohort of 50 fellow women leaders in GI as you: 👩⚕️ Build a network of peers who understand your journey. 💡 Learn practical strategies you can use right away. ✨ Recharge and refocus on your career goals. 📆Apply by Dec. 17 https://ow.ly/UANx50X4sqH
-
-
The latest issue of #CMGH is out now! 🔑 Key articles include: 🔴 FMO5 Plays a Sex-specific Role in Goblet Cell Maturation and Mucus Barrier Formation 🔴 Targeting Ferroptosis Restores the Antiviral Activity of CD8+ T Cells During Chronic #Hepatitis B Virus Infection 🔴 CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic #Pancreatitis 🔴 CMGH Reviews: From Comprehensive Narratives to Concise Insights 🔴 Celebrating 10 Years: Insights From CMGH’s Editorial Fellows Read the full issue here: https://ow.ly/ikcj50Xc2pm
-
-
American Gastroenterological Association (AGA) reposted this
The #DDW2026 abstract submission site is now open! We encourage you to share your latest discoveries with us for a chance to present at the premier meeting in #GI and #hepatology. 💻More info: https://ow.ly/28hA50XhsUG 📔Guidelines: https://ow.ly/mOU950XhsUF 🗓️Deadline: Dec. 4, 2025
-
-
📣 Join us on Nov. 4 for a Gastro Bites focused on how shifting from a reactive to proactive approach can save lives in the prevention of cirrhosis decompensation, a critical turning point in liver disease. This free, virtual session will explore how clinicians can move beyond reactive care and embrace proactive strategies to prevent complications before they arise. You’ll learn: ▪️Discuss the key drivers of liver disease progression ▪️Describe the burden of cirrhosis, from compensated to decompensated stages ▪️Identify emerging strategies to prevent decompensation 📅 Date: Virtually on Nov. 4, 2025, noon ET 🔗 https://ow.ly/LEXT50XeTct Sponsored by Salix Pharmaceuticals